Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Marketing’s upper middle embraces AI creative production
Scaled AI creative production is becoming ordinary among CMOS outside the billion dollar club.
‘It scared the hell out of me’: What brands have learned from creator partnerships
At Shoptalk Fall, brands like Favorite Daughter, SharkNinja and Bob’s Discount Furniture talked about what they’ve learned from working with creators.
Future of Marketing Briefing: Agency fees in creator deals are the next transparency headache for marketers
As creator marketing budgets grow, so do questions about what agencies are taking.